Skip to main content
. 2021 Aug 15;13(8):915–928. doi: 10.4251/wjgo.v13.i8.915

Figure 3.

Figure 3

Overall survival and progression-free survival. A and B: Overall survival (A) and progression-free survival (B) of the carbohydrate antigen 19-9-negative groups according to post-treatment neutrophil-to-lymphocyte ratio (NLR). Post-treatment NLR < 2.62 group showed significantly better overall survival and progression-free survival than post treatment NLR ≥ 2.62. NLR: Neutrophil-to-lymphocyte ratio.